These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6285703)

  • 1. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B; Vahlne A; Lycke E
    Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
    Klein RJ; Friedman-Kien AE
    J Invest Dermatol; 1984 Nov; 83(5):344-6. PubMed ID: 6208291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    Hardy WD
    Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 11. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD; McLaren C; Barry DW
    Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
    Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
    Stellbrink HJ; Albrecht H; Löning T; Greten H
    Klin Wochenschr; 1991 Apr; 69(6):274-8. PubMed ID: 1828096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a thymidine kinase inhibitor (L-653,180) on antiviral treatment of experimental herpes simplex virus infection in mice.
    Klein RJ; Czelusniak SM
    Antiviral Res; 1990; 14(4-5):207-14. PubMed ID: 2088206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
    Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.